Skip to main content
. 2021 Aug 17;12(4):e02018-21. doi: 10.1128/mBio.02018-21

TABLE 1.

Overview of vaccine adjuvant formulations

Adjuvant Formulation
Advax1 Inulin polysaccharide adjuvant alone with no TLR agonist
Advax2 Advax1 + 10 μg TLR9 agonist (CpG55.2)
Advax3 Aldeltin (special formulation containing alum OH) + 10 μg TLR9 agonist (CpG55.2)
Advax4 Advax1 + 10 ng TLR7/8 agonist
Advax5 Advax1 + 200 ng TLR4 agonist
Advax6 Advax1 + 5 μg TLR3 agonist
Advax7 Advax1 + 5 μg TLR2 agonist
Advax8 Advax1 + 1 μg TLR4 agonist (5 times more TLR4 agonist than Advax5)
Advax9 Inulin polysaccharide alone with no TLR agonist-improved antigen binding capacity vs Advax1